Long-term Follow-up of Intramedullary Spinal Cord Tumors: a Series of 202 Cases
Overview
Authors
Affiliations
Objective: To review a series of patients who underwent surgical removal of intramedullary spinal cord tumors, focusing on the long-term functional outcome, recurrence rates for the various tumors, and technical problems continually debated in neurosurgical practice.
Methods: From December 1972 to June 2003, 202 patients underwent removal of intramedullary tumors. Lesions were located in the cervical spinal cord in 61 patients (30%), at a dorsal site in 60 (29%), at a cervicodorsal site in 51 (25%), and in the medullary cone in 30 (15%). The most frequent histological tumor types were astrocytomas (86 patients, 42%) and ependymomas (68 patients, 34%).
Results: Of the 68 ependymomas, 55 (81%) were completely removed and 13 (19%) incompletely removed. In 66% of the patients (42 patients), the presenting signs and symptoms remained unchanged at long-term follow-up; in 25% (16 patients), they improved; and in 9% (6 patients), the clinical status worsened. Of the 27 Grade I astrocytomas, 22 (81%) were completely removed and 5 (19%) incompletely removed. Functional assessment of the 23 patients available at "late" follow-up showed that 26% (6 of 23 patients) had improved, 9% (2 of 23 patients) had worsened, and 66% (15 of 23 patients) remained unchanged from preoperative status. Conversely, of the 41 Grade II astrocytomas, only 5 (12%) were completely removed, and 10% had improved. None of the 18 Grade III to IV astrocytomas could be completely removed. In 61% (11 of 18 patients), the postoperative functional status worsened.
Conclusion: Determinant predictors of a good outcome after surgery for intramedullary spinal cord tumors are histological type of lesion, complete removal of the lesion, and a satisfactory neurological status before surgery.
Factors Determining Rehabilitation Needs After Intradural Spinal Tumor Surgery: A Prospective Study.
Krajewski S, Furtak J, Zawadka-Kunikowska M, Kachelski M, Sobon J, Harat M Brain Sci. 2025; 15(1).
PMID: 39851419 PMC: 11763721. DOI: 10.3390/brainsci15010051.
Chen D, Shao T, Zhu H, Gao X, Huang Q, Yang X Eur Spine J. 2024; 34(2):665-674.
PMID: 39653854 DOI: 10.1007/s00586-024-08601-2.
Panigrahi M, Koradia P, Kumar D, Dholke H, Vooturi S Surg Neurol Int. 2024; 15:370.
PMID: 39524591 PMC: 11544476. DOI: 10.25259/SNI_309_2024.
Soler-Rico M, Daoud L, Fomekong E Cureus. 2024; 16(9):e70296.
PMID: 39463493 PMC: 11512722. DOI: 10.7759/cureus.70296.
Dauleac C, Jacquesson T, Frindel C, Andre-Obadia N, Ducray F, Mertens P Cancers (Basel). 2024; 16(16).
PMID: 39199605 PMC: 11352615. DOI: 10.3390/cancers16162834.